Saliva and Blood THC Can Correlate Without Supporting a Reliable Conversion

A correlation between oral-fluid and blood THC does not establish that one specimen can reliably predict the other person’s concentration or effects. Controlled vaporization research found broad oral-fluid variability despite robust overall associations.

The study included alcohol co-use

Nineteen cannabis smokers participated in a within-person study of vaporized cannabis, with and without oral alcohol. Researchers collected oral fluid, blood and plasma and repeatedly measured subjective effects.

The analysis used measured THC and breath-alcohol concentrations after nominal cannabis-dose groups did not produce sufficiently distinct concentrations. Nominal product potency and actual exposure were therefore not interchangeable even inside the experiment.

Association is not agreement

Oral-fluid cannabinoid concentrations correlated with blood and plasma, but specimen ratios varied considerably. A correlation can describe a shared overall trend while leaving wide uncertainty around the prediction for an individual sample.

The authors found blood THC more consistent than oral fluid for modeling the reported intoxicating effects under the tested conditions. This was not validation of a universal blood threshold or a saliva-to-blood conversion factor.

Alcohol changed the time course

Alcohol prolonged some cannabis subjective effects. Concentration–effect relationships also showed hysteresis, meaning that time within the exposure course affected interpretation.

These were ratings of experience, not proof that every driving skill changed by the same amount. The study did not directly establish the cause of a particular crash or a universal waiting interval.

Important population limits

Participants using cannabis more than three days weekly were excluded, so the findings do not automatically describe very frequent users. Product, route, alcohol sequence and sampling time also matter.

When reviewing paired results, identify the collection device, analytes, matrices and timing. Treat saliva as its own specimen with its own uncertainties. An impressive correlation coefficient should not be used to conceal the variability that matters when interpreting one person’s result.

For context, see our discussion of THC concentrations and the separate question of impairment.

Primary research

Rebecca L. Hartman and colleagues. Controlled Vaporized Cannabis, With and Without Alcohol: Subjective Effects and Oral Fluid-Blood Cannabinoid Relationships. Drug testing and analysis (2015). DOI: 10.1002/dta.1839.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Higher Edible Dose Did Not Produce a Higher Mean Blood THC Peak in Every Group

A 50 mg edible THC dose did not produce a higher mean whole-blood THC peak than 25 mg in a small between-group study. That observation does not show reversed absorption or make blood concentration a reliable dose calculator. Only six people received each dose Healthy adults without recent cannabis use…

Spread the love

Read Article: A Higher Edible Dose Did Not Produce a Higher Mean Blood THC Peak in Every Group

Oral-Fluid Parent Cannabinoids and Metabolites Followed Different Route Patterns

An oral-fluid THC peak immediately after cannabis use can reflect material deposited in the mouth rather than peak systemic exposure. A controlled comparison of smoked, vaporized and edible cannabis found different route patterns for parent cannabinoids and metabolites. Within-person route comparisons Eleven frequent and nine occasional cannabis smokers completed a…

Spread the love

Read Article: Oral-Fluid Parent Cannabinoids and Metabolites Followed Different Route Patterns

Transdermal CBD’s Open-Label Seizure Improvement Did Not Reverse Its Blinded Null Result

Transdermal CBD did not significantly reduce seizure frequency compared with placebo during a blinded adult focal-epilepsy trial. Improvement during the later open-label extension answered a different question and did not overturn that randomized comparison. A daily-dose distinction clarified by correction The trial randomized 188 adults to transdermal CBD or placebo….

Spread the love

Read Article: Transdermal CBD’s Open-Label Seizure Improvement Did Not Reverse Its Blinded Null Result

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us